Celldex Reports Results From Mid Stage Study Of Barzolvolimab In Eosinophilic Esophagitis
ReutersAug 19, 2025 8:03 PM
Aug 19 (Reuters) - Celldex Therapeutics Inc CLDX.O:
CELLDEX REPORTS RESULTS FROM PHASE 2 STUDY OF BARZOLVOLIMAB IN EOSINOPHILIC ESOPHAGITIS (EOE)
CELLDEX THERAPEUTICS INC - PRIMARY ENDPOINT MET, NO IMPROVEMENT IN EOE SYMPTOMS
CELLDEX THERAPEUTICS INC - BARZOLVOLIMAB SHOWS FAVORABLE SAFETY PROFILE AT 300 MG Q4 WEEKLY
CELLDEX THERAPEUTICS INC - WILL NOT ADVANCE DEVELOPMENT IN EOE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
Starbucks FY2025 Third Quarter Earnings Comments
Starbucks reported quarterly revenue of $9.5 billion, surpassing market expectations of $9.45 billion, with a year-over-year increase of 4.28%. This growth was primarily driven by new store openings, with a global net addition of 308 stores, bringing the total to 41,097. North America saw 3% growth,TradingKey
Wed, Jul 30
[Reuters Analysis] Foreign demand for US Treasuries holds off bond vigilantes: McGeever
By Jamie McGeeverORLANDO, Florida, July 23 (Reuters) - So much for the bond vigilantes.The U.S. bond market has been remarkably calm lately, despite fears that inflation, tariffs, eroding Fed independence, and Washington's ballooning debt load will push up Treasury yields. What explains the resi...Reuters
Wed, Jul 23
What Is Stellar (XLM), and Why Did It Surge Over 110% in Just 7 Days?
Stellar isn’t just another altcoin — it’s a blueprint for a next-generation financial system. From remittances and stablecoin settlement to smart contracts and CBDC infrastructure, Stellar is redefining what “on-chain capital markets” can look like.TradingKey
Fri, Jul 18
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
Tradingkey
